Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Conference News ISET 2024

Venous Stents: How to Choose Among the Wealth of Options

Caitlin E. Cox

January 26, 2024

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

News Daily News

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

Todd Neale

January 11, 2022

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Daily News

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

Todd Neale

December 16, 2021

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

L.A. McKeown

November 15, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

FDA Approves Dabigatran for VTE in Children

Shelley Wood

June 22, 2021

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

Advertisement

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

Venous Stents: How to Choose Among the Wealth of Options

High-Sensitivity Troponins May Overestimate PE Severity

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

PAD Significantly Ups Morbidity and Mortality in AMICS

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

FDA Approves Two Additional Indications for Rivaroxaban in Children

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

Long-term Anticoagulation After Unprovoked VTE: New Insights

July/August 2021 News Roundup

FDA Approves Dabigatran for VTE in Children

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content